e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.

Devaraj A., Ottink F., Rennison-Jones C., Blé F-X., Joly O., Azim A., Gerry S., Harston G., Ostridge K., George PM.

DOI

10.1164/rccm.202312-2274LE

Type

Journal article

Publication Date

2024-05-01T00:00:00+00:00

Volume

209

Pages

1168 - 1169

Total pages

1

Keywords

Humans, Idiopathic Pulmonary Fibrosis, Tomography, X-Ray Computed, Disease Progression, Male, Female, Biomarkers, Aged, Middle Aged, Lung

Permalink More information Close